Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts.
HIV
PrEP
SARS-CoV-2
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
04
02
2022
accepted:
09
04
2022
entrez:
6
7
2022
pubmed:
7
7
2022
medline:
7
7
2022
Statut:
epublish
Résumé
The potential preventive efficacy of tenofovir/emtricitabine on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was assessed in human immunodeficiency virus preexposure prophylaxis (PrEP) users. Prevalence of SARS-CoV-2 immunoglobulin G between May and October 2020 was similar in PrEP users and in a matched population-based cohort, suggesting that tenofovir/emtricitabine has no role in reducing the risk of SARS-CoV-2 acquisition.
Identifiants
pubmed: 35791355
doi: 10.1093/ofid/ofac188
pii: ofac188
pmc: PMC9047207
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofac188Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
Clin Microbiol Infect. 2021 Nov;27(11):1678-1684
pubmed: 34186209
mBio. 2020 May 22;11(3):
pubmed: 32444382
BMC Infect Dis. 2021 Feb 10;21(1):169
pubmed: 33568097
Clin Infect Dis. 2021 Oct 5;73(7):e2005-e2015
pubmed: 32860699
J Biomol Struct Dyn. 2021 Jun;39(9):3204-3212
pubmed: 32338164
Ann Intern Med. 2020 Oct 6;173(7):536-541
pubmed: 32589451
J Clin Virol. 2020 Aug;129:104511
pubmed: 32593133
Antiviral Res. 2020 Aug;180:104857
pubmed: 32562705
BMJ Open. 2021 Nov 26;11(11):e051711
pubmed: 34836901
EClinicalMedicine. 2021 Aug;38:100993
pubmed: 34222849
Open Forum Infect Dis. 2020 Sep 25;7(11):ofaa455
pubmed: 33200081
Int J Epidemiol. 2021 Nov 10;50(5):1458-1472
pubmed: 34293141